Faculty Research Interests
Focuses on educational content development, delivery methods, and curriculum change assessment.
Faculty: Cayleigh Blumrick, MD; Catherine Derber, MD; Aaron Mills, MD; B. Mitchell Goodman, MD; A. Brooke Hooper, MD; Jody P. King, MD; David Lieb, MD; Mily
Kannarkat, MD, Elizabeth Batchelor, MD, Sarah Serji, DO
Some research studies:
• B. Mitchell Goodman, MD; A. Brooke Hooper, MD; Jody P. King, MD; Aaron E. Mills, MD: “Academic Faculty & Trainee Perceptions of Artificial Intelligence (AI)
in Clinical Medical Education – What is AI’s Role in Patient Education and Documentation?”
• A. Brooke Hooper, MD: Transitions in Medical Education: Themes from Learners in Training During a Pandemic”; “Video-Based Tracheostomy Care Education for
Medical Students”
Prospective, retrospective, and cross-sectional studies focusing on incidence, prevalence, risk factors, and time trends of various diseases
Faculty: Taylor Attar, DO; Catherine Derber, MD; James G. Dixon, MD; Ron Flenner, MD; Marisa Galicia-Castillo, MD; B. Mitchell Goodman, MD; Jody King, MD; Iulia Kovalenko, MD; David Lieb, MD; Alvin Maliakal, MD; Bahar Niknejad, MD; Chinelo Okigbo, MD/PhD; Hamid Okhravi, MD; Henri Parson, PhD; Rehan Qayyum, MD; Joshua Sill, MD; Sami Tahhan, MD;
• Marisa Galicia-Castillo, MD; Kelly A. Thomson, MD: “Scripting for Success: Improving the Palliative Care Medicine Inpatient Referral Process”
• Alvin Maliakal, MD: “Healing Hearts & Health with Caring Connections: Perceptions of Physician Compassion”
• Catherine Derber, MD: “Perception of Vaccine Hesitancy Among Patients Post COVID-19 Vaccine Mandates”
• James G. Dixon, MD: A Quality Improvement Project to Standardize Blood Pressure Assessment by Implementing “Non-routine” Blood Pressure Assessment Utilizing Automated Omron HEM 907 XL Oscillometric Blood Pressure Machines and Optimal Nursing Blood Assessment Preparation in the Internal Medicine Faculty / Resident Clinic, Hofheimer Hall.
• Hamid Okhravi, MD: “The Use of Virtual Reality to Improve Understanding, Empathy, and Self-Efficacy in Caregivers of Dementia Patients”
• David Lieb, MD; Chinelo Okigbo, MD/PhD, Taylor Attar, DO: “Prevalence of Medication non-Adherence and its Relationship with Diabetes Distress”
Generating new surveys for use in a variety of clinical settings; understanding the effect of health policy or interventions on patients and providers
Faculty: Rehan Qayyum, MD
Advancing insights into disease processes and clinical operations using data already collected for administrative or research purposes.
Faculty: Nathaniel Gordon, DO; Jennifer Hanrahan, DO; Nancy Morewitz, MD; Rehan Qayyum, MD; Joshua Sill, MD; Sami Tahhan, MD;
Some research Studies
- Sami Tahhan, MD: “State Adoption of Medicaid Expansion on Hospital Readmission Rates”
- Rehan Qayyum, MD: “Long-Term Effects of Financial Penalties on 30-day Hospital Readmission Rates”
- Rehan Qayyum, MD: “Anemia Prevalence Time-trends in the United States”
Faculty: Waleed Kassabo, MD; Rehan Qayyum, MD; Julie Sill, PhD; Kelly Thomson, MD
Anum Javaid, MD; Liza Botros, MD; Rehan Qayyum, MD: “Systematic review of the interventions hospitals have implemented to decrease heart failure readmissions”
Designing and testing new interventions for diagnosis or disease treatment.
A clinical trial is a research study that is designed to test the effectiveness of new medical treatments or other medical interventions. Each study is designed to answer scientific questions and to find better ways to treat individuals with a specific disease.
By participating in clinical trials, you help accelerate medical science by providing valuable insights into potential treatments and methods of prevention. Participants with an illness or disease participate to help others, but also to possibly receive the newest treatment and to have additional care and attention from the clinical trial staff.
All clinical trials conducted are approved by the university Institutional Review Board (IRB). For investigational treatments, all clinical trials are also approved by the FDA.
Faculty: Mark Flemmer, MD; David Johnson, MD; David Lieb, MD; Hamid Okhravi, MD; Henri Parson, PhD; Elias Siraj, MD
• Chinelo Okigbo, MD/PhD: “Reducing Diabetes Distress in Adults with Newly Diagnosed Type 2 Diabetes: A Pilot Study”
• Elias Siraj, MD: “FINE-One: A Parallel-Group, Randomized, Prospective, Interventional, Double-Blind, Multicenter Global Phase 3 Study to Investigate the Efficacy and Safety of Finerenone Versus Placebo, In Addition to Standard of Care, In Participants With Chronic Kidney Disease And Type 1 Diabetes”
• Henri Parson, PhD: “Nutritional Lifestyle-based Study: Impact Of A Culturally Tailored, Personalized, Mobile Health-Based Lifestyle Intervention In Improving Metabolic Outcomes Of Overweight And Obese African Americans With Prediabetes In Underserved Communities Of Southeastern Virginia”
• Hamid Okhravi, MD: “The Glennan Center Memory Consultation Clinic Registry
Project”
• Hamid Okhravi, MD: “AHEAD3-45: Clinical Trial Aimed to Help Prevent Memory Problems”